Location History:
- Menlo Park, CA (US) (2012 - 2023)
- Los Altos, CA (US) (2013 - 2023)
- South San Francisco, CA (US) (2023)
Company Filing History:
33 out of 50 
2 out of 37 
2 out of 832,880 Years Active: 2012-2025
Title: Innovations by Kathleen Cogan Farinas in Drug Delivery and Eye Treatment
Introduction
Kathleen Cogan Farinas is an accomplished inventor based in Menlo Park, California, recognized for her significant contributions to medical technology. With a remarkable portfolio of 37 patents, Farinas has focused her research and innovations on enhancing therapeutic delivery systems and diagnostic methods.
Latest Patents
Among her latest innovations is a patent for "Porous structures for extended release drug delivery devices," which describes a therapeutic device featuring a refillable reservoir designed to deliver a therapeutic agent over an extended period. This innovative structure incorporates a porous material near the outlet of the reservoir, facilitating controlled diffusion of the therapeutic agent while allowing for enhanced delivery characteristics by blocking undesired particle sizes through a barrier layer. Furthermore, she has developed diagnostic methods and apparatus aimed at treating patients, particularly involving a container that analyzes the fluid from devices implanted in the eye, enabling examination of the vitreous humor components.
Career Highlights
Kathleen has made notable strides in her career, working with reputable companies such as Forsight Vision4, Inc. and Mati Therapeutics Inc. Her dedication to advancing medical devices has positioned her as a leading figure in the field of innovative healthcare solutions.
Collaborations
Throughout her career, Farinas has collaborated with esteemed colleagues, including Randolph E. Campbell and Cary J. Reich. These partnerships have enriched her research and contributed to her success in developing groundbreaking medical technologies.
Conclusion
Kathleen Cogan Farinas continues to push the boundaries of innovation in drug delivery and diagnostic devices. Her extensive patent portfolio not only enhances patient care but also reflects her commitment to advancing medical technology. As she continues her work, her contributions are likely to impact the field significantly, improving therapeutic outcomes for patients worldwide.